Skip to main content
. 2017 May 31;14(2):1657–1664. doi: 10.3892/ol.2017.6282

Figure 1.

Figure 1.

Representative mRNA levels of PCDH8 from 4 patients with prostate cancer and the control. The mRNA level of PCDH8 was reduced in cases 22 and 24. The controls were samples from patients with benign prostatic hyperplasia. **P<0.01 compared with control; N.S., not significant compared with control. PCDH8, protocadherin 8.